Exosome in gastric cancer: research and perspective

Abstract

CLC Number:

R735.2

FAN Qingquan, SONG Xiaoling, GU Jun. Exosome in gastric cancer: research and perspective[J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 177-180.

References31

[1]	BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. doi:10.3322/caac.v68.6 URL
[2]	CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132. doi:10.3322/caac.21338 URL
[3]	SMYTH E C, NILSSON M, GRABSCH H I, et al. Gastric cancer[J]. Lancet, 2020, 396(10251):635-648. doi:S0140-6736(20)31288-5pmid:32861308
[4]	PAN B T, JOHNSTONE R M. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor[J]. Cell, 1983, 33(3):967-978. doi:10.1016/0092-8674(83)90040-5pmid:6307529
[5]	DOYLE L M, WANG M Z. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis[J]. Cells, 2019, 8(7):727. doi:10.3390/cells8070727 URL
[6]	VANNIEL G, D'ANGELO G, RAPOSO G. Shedding light on the cell biology of extracellular vesicles[J]. Nat Rev Mol Cell Biol, 2018, 19(4):213-228. doi:10.1038/nrm.2017.125 URL
[7]	RAPOSO G, STOORVOGEL W. Extracellular vesicles: exosomes, microvesicles, and friends[J]. J Cell Biol, 2013, 200(4):373-383. doi:10.1083/jcb.201211138pmid:23420871
[8]	ZHANG L, YU D. Exosomes in cancer development, metastasis, and immunity[J]. Biochim Biophys Acta Rev Cancer, 2019, 1871(2):455-468. doi:10.1016/j.bbcan.2019.04.004 URL
[9]	HANAHAN D, WEINBERG R A. Hallmarks of cancer: the next generation[J]. Cell, 2011, 144(5):646-674. doi:10.1016/j.cell.2011.02.013pmid:21376230
[10]	SHI S S, ZHANG H P, YANG C Q, et al. Exosomal miR-155-5p promotes proliferation and migration of gastric cancer cells by inhibiting TP53INP1 expression[J]. Pathol Res Pract, 2020, 216(6):152986. doi:10.1016/j.prp.2020.152986 URL
[11]	YOON J H, ASHKTORAB H, SMOOT D T, et al. Uptake and tumor-suppressive pathways of exosome-associated GKN1 protein in gastric epithelial cells[J]. Gastric Cancer, 2020, 23(5):848-862. doi:10.1007/s10120-020-01068-2pmid:32291710
[12]	NAKAMURA M, ONO Y J, KANEMURA M, et al. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantationviathe mesothelial-mesenchymal transition of the peritoneum[J]. Gynecol Oncol, 2015, 139(2):345-354. doi:10.1016/j.ygyno.2015.08.010 URL
[13]	ZHU M, ZHANG N, HE S, et al. Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasisviadirect regulation of Smad7[J]. Cell Cycle, 2020, 19(10):1200-1221. doi:10.1080/15384101.2020.1749467 URL
[14]	LI Q, LI B, LI Q, et al. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasisviamesothelial-to-mesenchymal transition[J]. Cell Death Dis, 2018, 9(9):854. doi:10.1038/s41419-018-0928-8
[15]	WANG J, GUAN X, ZHANG Y, et al. Exosomal miR-27a derived from gastric cancer cells regulates the transformation of fibroblasts into cancer-associated fibroblasts[J]. Cell Physiol Biochem, 2018, 49(3):869-883. doi:10.1159/000493218pmid:30184548
[16]	ZHANG X, SHI H, YUAN X, et al. Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration[J]. Mol Cancer, 2018, 17(1):146. doi:10.1186/s12943-018-0898-6pmid:30292233
[17]	WANG F, LI B, WEI Y, et al. Tumor-derived exosomes induce PD1(+) macrophage population in human gastric cancer that promotes disease progression[J]. Oncogenesis, 2018, 7(5):41. doi:10.1038/s41389-018-0049-3
[18]	XIA X, WANG S, NI B, et al. Hypoxic gastric cancer-derived exosomes promote progression and metastasisviamiR-301a-3p/PHD3/HIF-1α positive feedback loop[J]. Oncogene, 2020, 39(39):6231-6244. doi:10.1038/s41388-020-01425-6
[19]	LI W, LI C, ZHOU T, et al. Role of exosomal proteins in cancer diagnosis[J]. Mol Cancer, 2017, 16(1):145. doi:10.1186/s12943-017-0706-8pmid:28851367
[20]	XIA Y, HU X, DI K, et al. Combined detection of exosome concentration and tumor markers in gastric cancer[J]. J Biomed Nanotechnol, 2020, 16(2):252-258. doi:10.1166/jbn.2020.2887pmid:32252885
[21]	TANG S, CHENG J, YAO Y, et al. Combination of four serum exosomal miRNAs as novel diagnostic biomarkers for early-stage gastric cancer[J]. Front Genet, 2020, 11(4):237. doi:10.3389/fgene.2020.00237 URL
[22]	FU H, YANG H, ZHANG X, et al. Exosomal TRIM3 is a novel marker and therapy target for gastric cancer[J]. CA Cancer J Clin, 2018, 37(1):162.
[23]	YAMAMOTO H, WATANABE Y, OIKAWA R, et al. BARHL2 methylation using gastric wash DNA or gastric juice exosomal DNA is a useful marker for early detection of gastric cancer in an H. pylori-Independent Manner[J]. Clin Transl Gastroenterol, 2016, 7(7):e184. doi:10.1038/ctg.2016.40 URL
[24]	WANG S, PING M, SONG B, et al. Exosomal circPRRX1 enhances doxorubicin resistance in gastric cancer by regulating miR-3064-5p/PTPN14 signaling[J]. Yonsei Med J, 2020, 61(9):750-761. doi:10.3349/ymj.2020.61.9.750pmid:32882759
[25]	WANG X, ZHANG H, BAI M, et al. Exosomes serve as nanoparticles to deliver anti-miR-214 to reverse chemoresistance to cisplatin in gastric cancer[J]. Mol Ther, 2018, 26(3):774-783. doi:S1525-0016(18)30008-Xpmid:29456019
[26]	ZHANG Q, ZHANG H, NING T, et al. Exosome-delivered c-Met siRNA could reverse chemoresistance to cisplatin in gastric cancer[J]. Int J Nanomedicine, 2020, 15:2323-2335. doi:10.2147/IJN.S231214 URL
[27]	WANG J, LV B, SU Y, et al. Exosome-mediated transfer of lncRNA HOTTIP promotes cisplatin resistance in gastric cancer cells by regulating HMGA1/miR-218 Axis[J]. Onco Targets Ther, 2019, 1:11325-11338.
[28]	LI A, ZHAO Y, LI Y, et al. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles[J]. Drug Deliv, 2021, 28(1):1237-1255. doi:10.1080/10717544.2021.1938757pmid:34142930
[29]	KAWAZOE A, SHITARA K, BOKU N, et al. Current status of immunotherapy for advanced gastric cancer[J]. Jpn J Clin Oncol, 2021, 51(1):20-27. doi:10.1093/jjco/hyaa202pmid:33241322
[30]	XU Z, ZENG S, GONG Z, et al. Exosome-based immunotherapy: a promising approach for cancer treatment[J]. Mol Cancer, 2020, 19(1):160. doi:10.1186/s12943-020-01278-3pmid:33183286
[31]	LI Z, SUO B, LONG G, et al. Exosomal miRNA-16-5p derived from M1 macrophages enhances T cell-dependent immune response by regulating PD-L1 in gastric cancer[J]. Front Cell Dev Biol, 2020, 8:572689. doi:10.3389/fcell.2020.572689 URL

Exosome in gastric cancer: research and perspective

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References31

Related Articles15

Recommended Articles

Metrics

Comments

[1]	QIU Yucheng, ZHOU Xianyu, LIU Fei, et a.Application progress of mesenchymal stem cells and their exosomes in allotransplantation[J]. Journal of Tissue Engineering and Reconstructive Surgery, 2023, 19(2): 184-.
[2]	ZHU Zhenggang.Progress and prospect of surgical comprehensive treatment of gastric cancer[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 1-6.
[3]	ZHAO Fazhi, ZHAO Ping.Formation and improvement of surgery-based treatment system for gastric cancer[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 24-30.
[4]	LI Guoli, GUO Feilong.Preoperative chemotherapy through intra-arterial combined with intra-venous administration in treatment of advanced gastric cancer[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 31-35.
[5]	LIU Wentao, LIU Fukun.Summary and prospect of perioperative comprehensive treatment for gastric cancer in China[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 36-41.
[6]	ZHANG Huan, CHEN Yong.New progression of radiomics in diagnosis of gastric cancer[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 42-48.
[7]	DENG Shijie, YUAN Fei.Advances in diagnosis and molecular detection of EBV-positive gastric cancer and gastric cancer with lymphoid stroma[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 53-57.
[8]	LI Jianfang, YU Junxian, YAN Chao, ZHU Zhenggang, LIU Bingya.Hotspots in basic and translational research of gastric cancer[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 7-16.
[9]	LU Yiming, XIONG Jianping, TIAN Yantao.Current status and prospect of conversion therapy for far-advanced gastric cancer[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 17-23.
[10]	JI Ouyang, FANG Junyan, SONG Ahui, TONG Yan, WEI Shan, CHEN Zhihao, LIU Yingli.Effect of mesenchymal stem cells-derived exosomes on hyperglycemic injury of human peritoneal mesothelial cells[J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(4): 294-.
[11]	CHEN Hui, HOU Aihua, WANG Peipei, MEI Xiaofeng. .Construction of enhanced green fluorescent protein labeling bladder cancer exosomes and its tracing application in vitro[J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(4): 300-.
[12]	DAI Zhiqiang, ZHENG Jinxin, TANG Zhaoqing, ZHANG Qi, GU Yuan, SHI Zhongyi, HU Guohua, SUN Yihong.Metastatic lymph node ratio to evaluate prognosis of patients with stage Ⅱ-Ⅲ gastric cancer after radical gastrectomy[J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 429-434.
[13]	YANG Ruixin, DU Yutong, YAN Ranlin, ZHU Zhenggang, LI Chen, YU Yingyan.Improving exploration of biological sample pretreatment in single-cell transcriptome sequencing of gastrointestinal tumors[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(05): 567-574.
[14]	LI Nana, QI Tao, ZHU Liming.Clinical value of serum pepsinogen,gastrin 17 andHelicobacter pyloriIgG antibody in primary screening of gastric diseases[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 509-513.
[15]	NIE Mingming, ZHU Zhenggang.Clinical significance of diagnostic laparoscopy on precision staging in advanced gastric cancer[J]. Journal of Surgery Concepts & Practice, 2022, 27(04): 365-370.